Trial reportBrain and behavior2025
Effects of Repetitive Transcranial Magnetic Stimulation on Upper Limb Motor Function and Serum Lipid Metabolomics in Patients With Ischemic Stroke: A Randomized Controlled Study.
Trial report in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionRepetitive transcranial magnetic stimulation (rTMS) can reduce upper extremity motor dysfunction in patients with stroke. However, the optimal parameters and mechanisms of rTMS in stroke treatment remain unclear. Therefore, this study aimed to investigate the protective effect and mechanism of rTMS at different frequencies on the motor function of the upper limbs in patients with cerebral infarction using lipid metabolomics methods.
methodsA total of 102 participants were randomly assigned to receive sham rTMS, 1 Hz rTMS, and 10 Hz rTMS. All participants were assessed at baseline and 2 weeks later using the Fugl-Meyer Assessment upper extremity (FMA-UE), National Institutes of Health Stroke Scale (NIHSS), Barthel scales, and serum collection-lipid metabolomics analysis of serum samples by untargeted metabolomics.
resultsThe improvement in FMA-UE, NIHSS, and Barthel scores was more significant in 1 and 10 Hz rTMS groups than in the sham rTMS treatment group (p < 0.05). The improvement effect of FMA-UE (p < 0.05) and Barthel (p < 0.05) was significantly more potent with 1 Hz rTMS than with 10 Hz rTMS. There was no significant difference in NHISS (p > 0.05). After rTMS treatment of patients with ischemic stroke, differential metabolites of serum lipids included diacylglycerol phosphoinositide, triacylglycerol, and dialkyl glycerol.
conclusionBoth low- and high-frequency rTMS can effectively improve upper limb motor function and self-care ability in patients with ischemic stroke. However, the effect of low-frequency rTMS on improving upper limb motor function was more significant. Lipid metabolomics analysis revealed that high- and low-frequency rTMS increased diacylglycerol phosphoinositide and triacylglycerol levels and reduced dialkyl glycerol levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.